Kate Park / TechCrunch:

ImpriMed, which builds AI-powered drug response prediction tech for cancer in dogs, cats, and soon humans, raised a $23M Series A led by SoftBank Ventures Asia  —  ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify …

Kate Park / TechCrunch:

ImpriMed, which builds AI-powered drug response prediction tech for cancer in dogs, cats, and soon humans, raised a $23M Series A led by SoftBank Ventures Asia  —  ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify …

Source: TechMeme
Source Link: http://www.techmeme.com/231221/p27#a231221p27